Intrexon raises $200M in follow-on

Intrexon Corp. (NYSE:XON) raised $200 million through the sale of 4.9 million shares at $41 in a follow-on underwritten by JMP Securities; Stifel; Griffin Securities; and Wunderlich. Intrexon proposed the offering Thursday after market close, when its share price was $42.50.

The company is developing a series of chimeric antigen receptor (CAR) T cell therapies via partnerships with Ziopharm Oncology Inc. (NASDAQ:ZIOP) and Merck KGaA (Xetra:MRK). ...